In solid oral dosage operations for companion animals, the dried Citri Exocarpium Rubrum material is not used as a single-component system. The milled botanical fraction is typically blended with silicified microcrystalline cellulose at 20–35% w/w, croscarmellose sodium at 2–5% w/w, and magnesium stearate at 0.5–1.0% w/w to reach a target final tablet mass of 250–800 mg. Loss on drying after tray drying is held at ≤5.0% by Ph.Eur. 2.2.32 because residual moisture above this threshold produces punch filming on rotary presses running at 40–60 rpm. Bulk and tapped density measurements under Ph.Eur. 2.9.34 generally fall in the range 0.45–0.68 g/cm³, and the compressibility index is maintained at ≤25% to avoid weight variation; when the index exceeds 30%, dosator-based capsule filling becomes erratic. Hardness for immediate-release small-animal tablets is specified at 50–80 N with disintegration not exceeding 15 min in water at 37±2°C per Ph.Eur. 2.9.1, while dissolution for capsules is assessed by Ph.Eur. 2.9.3 using 900 mL of 0.1 N hydrochloric acid or phosphate buffer at pH 6.8, depending on the target release region. A production-scale observation in short-batch veterinary tableting is that batch-to-batch variation in citrus peel mesh fraction below 80 mesh alters flow consistency; milling through a 0.5 mm screen with pins at 3,000 rpm reduces coarse fibre, but attrition above 1.5% fines below 45 µm increases dust formation. Direct blending with sodium bicarbonate in effervescent formulations should be avoided because alkaline pH accelerates flavonoid oxidation and produces dark-coloured specks at 40°C/75% RH within 7 days. For capsules, the fill plug is formed at compression thickness 1.5–2.0 mm on dosator machines; reducing moisture below 3.0% may increase static charge and should be avoided unless humidification at 45–55% RH is applied before filling.

Why Soluble Powder Processes Fail When Extract Moisture Exceeds Acceptance Limits

The physical state of the botanic starting material controls reconstitution behaviour in drinking-water medication more than assay alone. If the exocarp fraction is micronized to D90 ≤45 µm and dry-blended with lactose monohydrate or dextrose monohydrate as a water-soluble carrier, the mixture can be diluted into drinking water at ratios between 1:500 and 1:1000; however, colloidal silicon dioxide at 0.5–2.0% w/w is required to maintain free flow on transfer lines and to prevent caking at 75% RH during storage. A V-blender or horizontal ribbon blender operated at 15–25 rpm for 15–30 min provides blend uniformity measured by Ph.Eur. 2.9.40, with individual top/middle/bottom samples reporting active content relative standard deviation ≤5%. The principal process failure is moisture ingress into the botanical material: at 6–8% loss on drying, the powder bridges in hoppers, static charges cause stratification, and dissolution time in water at 20°C rises beyond 2 min without high-shear agitation. For field use, the reconstituted dispersion should be prepared in cool water below 25°C; above this temperature, volatile oil droplets may coalesce and adhere to polyethylene drinker lines, reducing dose uniformity. Water hardness above 500 mg/L as calcium carbonate can generate turbidity and flocculation through calcium–flavonoid interaction; if the target water supply exceeds this value, citric acid at 1–2% w/v is incorporated into the soluble powder matrix as a chelating acidifier. The formulation is not a true solution, but a stabilized fine dispersion; therefore light-obscuration particle counting under Ph.Eur. 2.9.19 should be performed only after the product is reconstituted at the final drinking water concentration, and the particle count is accepted on a product-specific basis. Published data for the hydration behaviour of this specific red exocarp grade in hard water is limited, so incoming water quality must be evaluated at each farm site before treatment.

Premix Manufacturing Does Not Tolerate Unspecified Particle-Size Bimodality

The conversion of the exocarp fraction into a medicated premix for feed incorporation is less sensitive to palatability and more sensitive to severe segregation. The botanical powder exhibits a bimodal particle-size distribution when the outer peel is milled without classification: coarse fibre above 500 µm and fine flavanone-rich particles below 75 µm separate during pneumatic conveying, leading to active content drift in the final feed. A stepwise geometric dilution is used, beginning with a 1:10 dilution into wheat bran or ground maize, followed by another 1:10 dilution, before addition to a 500 kg ribbon mixer. Mixing time is determined by coefficient of variation testing on 10 samples, with acceptance at ≤5% CV at a final feed addition rate of 1 kg/t. The carry-over limit for subsequent non-medicated feed is controlled under Regulation EU 2019/4; for botanical actives, the maximum carry-over is not automatically fixed at 1% of the previous batch unless a product-specific limit is justified with validated cleaning data. Dust control systems with local exhaust ventilation capture velocities of 0.5–1.0 m/s are used because the fine fraction causes operator exposure and cross-contamination of adjacent lines. The use of vegetable oil as a binder at 0.5–1.5% w/w of premix suppresses dust but can reduce flowability if added before final comminution; in one production-scale observation, adding oil before final sieving increased retained material on a 125 µm sieve and led to CV values above 8% until the pass was repeated. If the premix is later pelleted, steam conditioning at 70–80°C for 30–45 s can degrade heat-sensitive flavanones unless throughput is increased to reduce residence time; published data for this specific red citrus exocarp in pelleted feed is limited, so production batches should include assay of naringin or hesperidin before and after pelleting to confirm recovery.

During granulation for top-dressed oral granule presentations, the water retention of the red citrus exocarp becomes a limiting variable. The material is wet-massed in a high-shear mixer with a binder solution of povidone K-30 at 3–5% w/w in purified water; the liquid-to-solid ratio must be held within 0.22–0.28 for batches up to 100 kg. A low-shear planetary mixer run at 60–80 rpm for 8–12 min produces granules with a narrower size distribution than prolonged high-shear mixing, which tears the wet mass and generates a high proportion of fines below 180 µm. Extrusion through a 0.6–0.8 mm screen followed by spheronization at 400–800 rpm yields pellets; but if the peel fraction contains residual peel oil above 1.0%, the pellets may become tacky and require talc at 1–2% w/w as an anti-adherent. Drying in a fluid-bed dryer at inlet air temperature 50–60°C for 20–30 min is preferred over tray drying at 70°C because thermal exposure above 70°C darkens the granules and reduces total flavanone assay. Sieve analysis by Ph.Eur. 2.9.12 typically targets a granule fraction between 200 µm and 850 µm at ≥80% of total mass; material below 200 µm is reworked at no more than 20% of subsequent batch size to avoid hardness drift. For feline or canine top dressing, the finished granule is blended with yeast extract at 1–2% w/w to reduce feed refusal caused by bitter flavonoid components; however, published palatability data for this specific botanical source are limited, and acceptance must be confirmed in target species small-panel testing. Granule packaging in aluminium foil-laminated sachets is used because the exocarp fraction is hygroscopic and oxygen-sensitive; unpackaged bulk product at 25°C/60% RH shows visible colour shift and caking within 14 days.

Parenteral Purification Barriers in Flavonoid-Rich Botanical Extracts

Injectable presentations impose removal of cell-wall fragments, polysaccharides, proteins, and endotoxin before the Citrus exocarp material is suitable for final compounding. A crude ethanolic extract that contains suspended fibre above 10 µm cannot be sterilized by a 0.22 µm polyethersulfone membrane without severe flux decay; the membrane may blind after 2–3 L/m² if the feed is not preclarified. Centrifugation at 10,000×g for 15 min followed by 0.45 µm depth filtration reduces the turbidity from over 100 NTU to below 15 NTU, but some polysaccharide aggregates persist. Ultrafiltration with a molecular weight cutoff of 100 kDa separates oligosaccharides and colloidal polymers from flavanone monomers; without this step, the solution may gel during terminal sterilization at 121°C for 15 min. The final aqueous vehicle is generally adjusted to pH 5.0–6.0 with citrate or phosphate buffer because the flavanone glycosides naringin and hesperidin are more stable in weakly acidic media; alkaline pH above 7.5 accelerates oxidation and causes brown discolouration at 40°C within 48–72 h. Co-solvent systems containing propylene glycol at 20–40% v/v or ethanol at 10–20% v/v are commonly required, but the final solution must be tested for visible particles under Ph.Eur. 2.9.20 and for sub-visible particles under Ph.Eur. 2.9.19 at release and after storage at 2–8°C for 6 months; precipitation can occur when the product is cooled because the solubility of polymethoxylated flavones drops sharply below 10°C. Bacterial endotoxin testing by Ph.Eur. 2.6.14 is mandatory, with an acceptance limit derived from the maximum labelled parenteral dose; small-batch veterinary parenteral preparations must use Water for Injections quality during extraction and dilution, and the final container must be terminally sterilized or aseptically filtered after endotoxin removal. The presence of citrus peel pigments can interfere with photometric assay, so HPLC with diode-array detection at 280–300 nm is used instead of direct spectrophotometry. Published data for this specific red exocarp in injectable form are limited; therefore, the purification train is validated per product, and each batch is assessed against the full parenteral impurity profile.

When the Material Is Directly Compounded into Liquid Oral Drenches

On a cattle or sheep drench production line, the Citrus exocarp fraction is handled as a dispersible ingredient in an aqueous or co-solvent vehicle, not as a fully soluble active. The manufacturing operation starts with a high-shear mixing vessel, not a simple magnetic stirrer, because the botanical matter lacks complete aqueous solubility. Purified water is heated to 30–40°C and the extracted active is added under recirculation; the temperature is not allowed to exceed 50°C because volatile constituents in the exocarp cause excessive foaming and degrade heat-sensitive flavanones. A typical suspending vehicle includes microcrystalline cellulose and carboxymethylcellulose sodium at 0.3–0.6% w/w, polysorbate 80 at 0.1–0.2% w/w, and sodium benzoate at 0.1% w/w; the final viscosity is kept below 50 mPa·s at 25°C to remain compatible with standard drench guns. Homogeneity is confirmed by recirculation for at least 20 min and sampling from the top, middle, and bottom of the tank, with active content relative standard deviation ≤3% before filling. The filling line is configured for continuous agitation to prevent sedimentation in the hopper; if the suspension stands for more than 30 min without recirculation, flocculation occurs and dose uniformity fails. Preservative efficacy is verified by Ph.Eur. 5.1.3 or USP 51; botanical materials with high polysaccharide content can reduce preservative availability, so the sodium benzoate concentration may require adjustment to the upper end of its compendial range. The final drench is packaged in amber HDPE bottles because light exposure at 400–500 nm accelerates oxidative discolouration. For field administration, the product should be used within 28 days after opening, and the bottle should be shaken before each use; although this is a conventional veterinary drench requirement, stability in multiple farm water temperatures should be confirmed with on-site testing. Published data for this specific red citrus exocarp in drench form is limited, so accelerated stability at 25°C/60% RH and 40°C/75% RH is used to define shelf life.